Find out more about the overall breast cancer treatment landscape, as biotech companies make progress with different ...

Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine technology ...

BioNTech is expanding its oncology pipeline with FixVac, iNeST, and BNT327 for individualized cancer treatments. Read why I ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...

Researchers found no link between COVID vaccination in early pregnancy and birth defects, results show. There were also no ...

In a big breakthrough for cancer treatment, Dr. Vinod Balachandran, a surgeon-scientist at Memorial Sloan Kettering Cancer ...

Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with the aim of reducing manufacturing costs and enabling additional therapeutic ...

Citigroup started coverage on shares of BioNTech (NASDAQ:BNTX – Free Report) in a report issued on Thursday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $145.00 target ...

Analysts at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for shares of BioNTech in a research report ...

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...

Fintel reports that on March 13, 2025, Citigroup initiated coverage of BioNTech SE - Depositary Receipt () (NasdaqGS:BNTX) ...

Citi analyst Geoff Meacham initiated coverage of BioNTech (BNTX) with a Buy rating and $145 price target Healthcare policy remains a key ...